Role of Neutrophil to Lymphocyte Ratio or Platelet to Lymphocyte Ratio in Prediction of Bone Metastasis of Prostate Cancer

被引:12
|
作者
Zhang, Jing-Ya [1 ]
Ge, Peng [1 ]
Zhang, Peng-Yu [1 ]
Zhao, Meng [1 ]
Ren, Li [1 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Dept Clin Lab,Tianjins Clin Res Ctr Canc, Huanhu Rd, Tianjin 300060, Peoples R China
基金
中国国家自然科学基金;
关键词
neutrophil to lymphocyte ratio; platelet to lymphocyte ration; prostate cancer; bone metastases; PRETREATMENT NEUTROPHIL; INFLAMMATION;
D O I
10.7754/Clin.Lab.2018.181040
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Accumulating evidence has revealed that inflammation might play an important role in the genesis and development of cancer. High levels of neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ration (PLR) are parameters of systemic inflammation which have been identified to be associated with poor prognosis in PCa. Bone is one of the most common sites of metastasis from prostate cancer; however, there are few studies concerning the correlation of NLR, PLR, and bone metastases in PCa. The aim of this study was to evaluate the performance of neutrophil to lymphocyte ratio (NLR) or platelet to lymphocyte (PLR) in diagnosis of bone metastasis of prostate cancer (PCa). Methods: Data of 74 PCa patients without metastases, 51 PCa patients with bone metastases, and 43 patients with benign prostatic hypertrophy (BPH) were retrospectively reviewed. The difference of patients' clinical and laboratory characteristics of the three groups was comparatively studied. ROC analysis was used to evaluate the benefit of adding NLR or PLR to prostate specific antigen (PSA) in prediction of bone metastases. Depending on this cutoff value, patients were divided into high-NLR or low-NLR group, high-PLR or low-PLR group. Results: There were significant differences in NLR and PLR between groups with bone metastases and without bone metastases (p = 0.044; p = 0.030), while there was no significant difference between NLR and PLR of the patients with localized prostate cancer and BPH (p = 0.462; p = 0.102). NLR and PLR were correlated with PSA level in the patients with prostate cancer (p = 0.006, r = 0.247; p = 0.025, r = 0.200). The distribution of PSA showed significant differences between the high-NLR and low-NLR group, as well as between the high-PLR and low-PLR group. By applying the ROC curve method, the AUC values of PSA with NLR or PLR were 0.725 and 0.838 (0.763 -0.913), respectively. Although PSA + PLR had the largest area, there was no statistical significance between PSA + PLR and PSA (p = 0.6992). Conclusions: NLR and PLR significantly increase in PCa patients with bone metastases and are valuable in the diagnosis of bone metastases in PCa patients.
引用
收藏
页码:853 / 858
页数:6
相关论文
共 50 条
  • [31] Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in patients with rheumatoid arthritis
    Peng, You-Fan
    Cao, Ling
    Zeng, Yan-Hua
    Zhang, Zhao-Xia
    Chen, Dan
    Zhang, Qiong
    Zhu, You-Sen
    OPEN MEDICINE, 2015, 10 (01): : 249 - 253
  • [32] The evaluation of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in anorectal abscess
    Akalin, Cagri
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2020, 26 (06): : 887 - 892
  • [33] Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio
    Ferroni, Patrizia
    Riondino, Silvia
    Formica, Vincenzo
    Cereda, Vittore
    Tosetto, Livia
    La Farina, Francesca
    Valente, Maria Giovanna
    Vergati, Matteo
    Guadagni, Fiorella
    Roselli, Mario
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) : 1234 - 1240
  • [34] The role of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) andmonocyte - lymphocyte ratio (MLR) in prognosis of breast cancer patients
    Huszno, J.
    Kolosza, Z.
    Kwarciak, J. Mrochem
    Rutkowski, T.
    Skladowski, K.
    CANCER RESEARCH, 2019, 79 (04)
  • [35] Neutrophil-to lymphocyte ratio in prediction of high grade prostate cancer
    Foran, A.
    Lundon, D. J.
    O'Reilly, E.
    Kelly, B. D.
    Hegarty, N.
    Connolly, S.
    O'Malley, K.
    BJU INTERNATIONAL, 2016, 118 : 32 - 33
  • [36] COMMENT ON "PROGNOSTIC SIGNIFICANT OF NEUTROPHIL: LYMPHOCYTE RATIO, PLATELET - LYMPHOCYTE RATIO, AND LYMPHOCYTE: MONOCYTE RATIO IN KURDISH PATIENTS WITH BREAST CANCER"
    Pellicciaro, M.
    Berardi, S.
    Materazzo, M.
    Vanni, G.
    WORLD CANCER RESEARCH JOURNAL, 2022, 9
  • [37] Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and monocyte to lymphocyte ratio in depression: A meta-analysis
    Su, Mi
    Ouyang, Xiaoxiao
    Song, Yongyan
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 308 : 375 - 383
  • [38] Neutrophil Lymphocyte Ratio, Monocyte Lymphocyte Ratio, Platelet Lymphocyte Ratio in Covid-19 Patients
    Sener, Gulsen
    Bayrak, Tulin
    Cokun, Cihan
    Bayrak, Ahmet
    CLINICAL LABORATORY, 2022, 68 (03) : 565 - 573
  • [39] The predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in determining cervical cancer stage
    Teoh, D. G. K.
    Vogel, R. Isaksson
    Monu, M.
    Lundstrom, Z.
    Albertin, C.
    Stockwell, E.
    Rivard, C.
    Geller, M. A.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 83 - 83
  • [40] The prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in nasopharyngeal cancer
    Gundog, Mete
    Basaran, Hatice
    JOURNAL OF BUON, 2020, 25 (01): : 367 - 375